Table 2

Radioactivity excretion (mean ± S.D.)^2-a after a single 120-mg oral dose or 60-mg intravenous infusion of [¹⁴C]nateglinide in male subjects

Sample	Time Interval	Radioactivity
Sample	Time Interval	Oral Dose	Intravenous Dose
	h	% Dose
Urine	0–6	71.7 ± 4.94	75.4 ± 3.69
	6–12	9.25 ± 2.91	8.92 ± 1.36
	12–24	2.03 ± 0.43	1.95 ± 0.32
	24–48	0.50 ± 0.13	0.55 ± 0.17
	48–72	0.10 ± 0.03	0.09 ± 0.06
	72–96	0.06 ± 0.03	0.01 ± 0.02
	96–120	0.04 ± 0.02	0.01 ± 0.02
	0–120	83.7 ± 4.14	86.9 ± 4.47
Feces	0–24	1.38 ± 1.83	0.10 ± 0.08
	24–48	5.30 ± 2.75	3.52 ± 2.22
	48–72	4.28 ± 3.23	3.97 ± 2.82
	72–96	0.78 ± 0.65	0.90 ± 1.32
	96–120	0.08 ± 0.10	0.59 ± 1.20
	0–120	10.0 ± 1.25	8.22 ± 1.09
Total	0–120	93.7 ± 4.92	95.1 ± 4.65

↵2-a n = 6.